Detalhe da pesquisa
1.
Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein.
Nat Commun
; 13(1): 4831, 2022 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977933